📖

Retigabine PD Trial

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-retigabine-pd

Related Entities

clinical-trials-retigabine-pd

Metadata

slug	clinical-trials-retigabine-pd
entity_type	clinical
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (41)

see_also📖CNTNAP4 Gene60%

see_also📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%

see_also📖entities-gba160%

see_also📖LRRK2 G2019S Transgenic Mouse Model60%

see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖APOB Gene60%

see_also📖DOT1L Gene60%

see_also📖eef1a160%

see_also📖IDH1 Gene - Isocitrate Dehydrogenase 160%

see_also📖MCL1 Gene - Myeloid Cell Leukemia 160%

mentions🧪Microbial Inflammasome Priming Prevention50%

mentions🧪Smartphone-Detected Motor Variability Correction50%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Arginine Methylation Enhancement Therapy50%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

related🧪SASP-Mediated Cholinergic Synapse Disruption50%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement50%

related🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne44%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%

mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise44%

mentions🧫Nrf2 inhibitor ML385 mechanism validation experiment44%

mentions🧫Acteoside treatment in LPS-induced SALI mouse model44%

mentions🧫Acteoside effects on RAW264.7 macrophage cells44%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice44%

mentions🧫TLR expression in α-synuclein overexpressing mice44%

mentions🧫Dexamethasone treatment study in α-synuclein mice44%

mentions🧫Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr44%

mentions🧫Functional analysis of EFNB1-EPHB4 interaction in EMT44%

mentions🧫Spatial transcriptomic analysis of multistage ESCC developme44%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy40%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise40%

mentions🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design40%

mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel40%

mentions🧫Tau ASO Therapy40%